MAPT and tauopathy: Given the growing efforts to model FTLD tauopathy using cell models derived from patients with FTLD-tau/MAPT [13–15], we reasoned that an assessment of VEN and fork cell vulnerability in this patient group could provide an important backdrop for the field.